SciVision Biotech Inc.

TWSE:1786 주식 보고서

시가총액: NT$6.6b

SciVision Biotech 대차 대조표 상태

재무 상태 기준 확인 6/6

SciVision Biotech 의 총 주주 지분은 NT$1.8B 이고 총 부채는 NT$137.0M, 이는 부채 대 자기자본 비율을 7.5% 로 가져옵니다. 총자산과 총부채는 각각 NT$2.1B 및 NT$321.6M 입니다. SciVision Biotech 의 EBIT는 NT$249.1M 이며 이자보상배율은 -18.4 입니다. NT$782.4M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

7.5%

부채 비율

NT$137.00m

부채

이자 보상 비율-18.4x
현금NT$782.42m
주식NT$1.82b
총 부채NT$321.64m
총 자산NT$2.15b

최근 재무 상태 업데이트

Recent updates

Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?

Oct 11
Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Aug 30
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

Jul 22
SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

Jun 28
SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Jun 14
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Jun 04
SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

재무 상태 분석

단기부채: 1786 의 단기 자산 ( NT$1.0B )이 단기 부채( NT$123.4M ).

장기 부채: 1786 의 단기 자산( NT$1.0B )이 장기 부채( NT$198.2M ).


부채 대 자본 내역 및 분석

부채 수준: 1786 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: 1786 의 부채 대 자기자본 비율은 지난 5년간 21.8% 에서 7.5% 로 감소했습니다.

부채 범위: 1786 의 부채는 영업 현금 흐름 ( 183% )에 의해 잘 충당되었습니다.

이자 보장: 1786 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.


대차 대조표


건강한 기업 발견하기